Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „sofosbuvir“
Suchtreffer
Begriffe & Kennungen
Sovaldi · 4.8 · Patients awaiting liver transplantation The safety profile of sofosbuvir and ribavirin in HCV infected adult p
Eintrag öffnenSovaldi · 4.8 · Patients awaiting liver transplantation The safety profile of sofosbuvir and ribavirin in HCV infected adult p
Eintrag öffnenSovaldi · 4.8 · Patients with Renal Impairment Sofosbuvir in a fixed dose combination with ledipasvir was administered for 12
Eintrag öffnenSovaldi · 4.8 · Patients with Renal Impairment Sofosbuvir in a fixed dose combination with ledipasvir was administered for 12
Eintrag öffnenSovaldi · 4.8 · Table 6: Adverse drug reactions identified with sofosbuvir in combination with ribavirin or peginterferon alfa
Eintrag öffnenSovaldi · 4.8 · Table 6: Adverse drug reactions identified with sofosbuvir in combination with ribavirin or peginterferon alfa
Eintrag öffnenSovaldi · 4.8 · The following adverse drug reactions have been identified with sofosbuvir in combination with ribavirin or in
Eintrag öffnenSovaldi · 4.8 · The following adverse drug reactions have been identified with sofosbuvir in combination with ribavirin or in
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · 20 2 The predominant circulating metabolite of sofosbuvir. 3 Study conducted with additional voxilaprevir 100
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 39% Cmax: ↑ 48% Cmin: ↑ 47% Sofosbuvir Sofosbuvir: No dose adjustment is (400 mg q.d.) + AUC
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 39% Cmax: ↑ 55% Cmin: ↑ 52% Sofosbuvir/Velpatasvir Sofosbuvir: Increased plasma (400 mg/100
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 40% Cmax: ↑ 44% Cmin: ↑ 84% Sofosbuvir/Velpatasvir/ Sofosbuvir: Increased plasma Voxilaprevi
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 40% Cmax: ↑ 46% Cmin: ↑ 70% Sofosbuvir/Velpatasvir Sofosbuvir: Concomitant (400 mg/100 mg q.
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 40% Cmax: ↔ Cmin: ↑ 91% Ledipasvir/Sofosbuvir Sofosbuvir: No dose adjustment is (90 mg/400 m
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 50% Cmax: ↑ 64% Cmin: ↑ 59% Ledipasvir/Sofosbuvir Ledipasvir: No dose adjustment is (90 mg/4
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 81% Cmax: ↑ 77% Cmin: ↑ 121% Sofosbuvir/Velpatasvir Sofosbuvir: No dose adjustment is (400 m
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 98% Cmax: ↑ 79% Cmin: ↑ 163% Ledipasvir/Sofosbuvir Ledipasvir: No dose adjustment is (90 mg/
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↔ Cmax: ↑ 25% Cmin: ↔ 1 Data generated from simultaneous dosing with ledipasvir/sofosbuvir. St
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↔ Cmax: ↑ 47% Cmin: ↑ 47% Ledipasvir/Sofosbuvir Ledipasvir: Increased plasma (90 mg/400 mg q.d
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↔ Cmax: ↑ 55% Cmin: ↑ 39% Sofosbuvir/Velpatasvir Sofosbuvir: Increased plasma (400 mg/100 mg q
Eintrag öffnen